HEADER ISOMERASE/VIRAL PROTEIN 12-JAN-10 2X2D TITLE ACETYL-CYPA:HIV-1 N-TERM CAPSID DOMAIN COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A; COMPND 3 CHAIN: B, C; COMPND 4 SYNONYM: PPIASE A, ROTAMASE A, CYCLOPHILIN A, CYCLOSPORIN A-BINDING COMPND 5 PROTEIN, CYPA; COMPND 6 EC: 5.2.1.8; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CAPSID PROTEIN P24; COMPND 10 CHAIN: D, E; COMPND 11 FRAGMENT: RESIDUES 133-278; COMPND 12 SYNONYM: CA, GAG POLYPROTEIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VARIANT: C41; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: POPTH; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 11 ORGANISM_TAXID: 11676 KEYWDS ISOMERASE-VIRAL PROTEIN COMPLEX, ISOMERASE VIRAL PROTEIN COMPLEX, KEYWDS 2 VIRAL PROTEIN, ISOMERASE, HOST-VIRUS INTERACTION EXPDTA X-RAY DIFFRACTION AUTHOR M.LAMMERS,H.NEUMANN,J.W.CHIN,L.C.JAMES REVDAT 4 24-JAN-18 2X2D 1 SOURCE REVDAT 3 26-OCT-11 2X2D 1 JRNL REMARK REVDAT 2 13-JUL-11 2X2D 1 VERSN REVDAT 1 23-MAR-10 2X2D 0 JRNL AUTH M.LAMMERS,H.NEUMANN,J.W.CHIN,L.C.JAMES JRNL TITL ACETYLATION REGULATES CYCLOPHILIN A CATALYSIS, JRNL TITL 2 IMMUNOSUPPRESSION AND HIV ISOMERISATION JRNL REF NAT.CHEM.BIOL. V. 6 331 2010 JRNL REFN ISSN 1552-4450 JRNL PMID 20364129 JRNL DOI 10.1038/NCHEMBIO.342 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0100 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 66.30 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 37521 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1975 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.00 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2829 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.90 REMARK 3 BIN R VALUE (WORKING SET) : 0.2730 REMARK 3 BIN FREE R VALUE SET COUNT : 144 REMARK 3 BIN FREE R VALUE : 0.3390 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4720 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 208 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.39 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.82000 REMARK 3 B22 (A**2) : 1.25000 REMARK 3 B33 (A**2) : 0.39000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.46000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.207 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.186 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.142 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.158 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.908 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4827 ; 0.021 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3325 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6512 ; 1.777 ; 1.946 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8082 ; 1.001 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 603 ; 6.715 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 214 ;36.828 ;24.486 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 813 ;17.221 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 24 ;19.602 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 696 ; 0.113 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5379 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 955 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3016 ; 1.076 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1253 ; 0.297 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4845 ; 1.866 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1811 ; 2.840 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1667 ; 4.450 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1 B 165 REMARK 3 ORIGIN FOR THE GROUP (A): 11.8015 2.0060 -18.6149 REMARK 3 T TENSOR REMARK 3 T11: 0.0190 T22: 0.0241 REMARK 3 T33: 0.0279 T12: -0.0133 REMARK 3 T13: 0.0147 T23: -0.0117 REMARK 3 L TENSOR REMARK 3 L11: 0.7534 L22: 0.8912 REMARK 3 L33: 1.6726 L12: -0.0353 REMARK 3 L13: 0.1509 L23: 0.2985 REMARK 3 S TENSOR REMARK 3 S11: 0.0197 S12: 0.0360 S13: 0.0294 REMARK 3 S21: -0.0178 S22: -0.0039 S23: -0.0476 REMARK 3 S31: 0.0947 S32: -0.0460 S33: -0.0158 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 1 C 165 REMARK 3 ORIGIN FOR THE GROUP (A): -12.9064 -41.3235 -17.8416 REMARK 3 T TENSOR REMARK 3 T11: 0.0429 T22: 0.0122 REMARK 3 T33: 0.0151 T12: -0.0102 REMARK 3 T13: -0.0158 T23: 0.0016 REMARK 3 L TENSOR REMARK 3 L11: 1.3501 L22: 2.0296 REMARK 3 L33: 1.8729 L12: -0.5307 REMARK 3 L13: 0.5320 L23: 0.3777 REMARK 3 S TENSOR REMARK 3 S11: 0.0289 S12: 0.0688 S13: -0.0165 REMARK 3 S21: -0.2032 S22: -0.0220 S23: 0.0957 REMARK 3 S31: -0.1000 S32: 0.1167 S33: -0.0069 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D 0 D 146 REMARK 3 ORIGIN FOR THE GROUP (A): 6.5210 -28.3359 11.8779 REMARK 3 T TENSOR REMARK 3 T11: 0.0314 T22: 0.0358 REMARK 3 T33: 0.0842 T12: 0.0047 REMARK 3 T13: 0.0096 T23: 0.0126 REMARK 3 L TENSOR REMARK 3 L11: 0.7570 L22: 0.7916 REMARK 3 L33: 0.8476 L12: 0.3626 REMARK 3 L13: 0.5262 L23: 0.4948 REMARK 3 S TENSOR REMARK 3 S11: -0.0413 S12: 0.0991 S13: 0.0651 REMARK 3 S21: 0.0131 S22: 0.0298 S23: -0.0626 REMARK 3 S31: -0.0769 S32: -0.0286 S33: 0.0116 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : E 0 E 146 REMARK 3 ORIGIN FOR THE GROUP (A): -8.6828 -10.1890 12.1059 REMARK 3 T TENSOR REMARK 3 T11: 0.0924 T22: 0.1196 REMARK 3 T33: 0.0643 T12: -0.0743 REMARK 3 T13: -0.0248 T23: 0.0052 REMARK 3 L TENSOR REMARK 3 L11: 0.7044 L22: 1.0345 REMARK 3 L33: 2.1898 L12: 0.4026 REMARK 3 L13: -1.1388 L23: -0.7061 REMARK 3 S TENSOR REMARK 3 S11: -0.1108 S12: 0.2179 S13: 0.0213 REMARK 3 S21: 0.1460 S22: 0.0752 S23: -0.0099 REMARK 3 S31: 0.0606 S32: -0.2401 S33: 0.0356 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. ATOM RECORD CONTAINS RESIDUAL B FACTORS ONLY REMARK 4 REMARK 4 2X2D COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-JAN-10. REMARK 100 THE DEPOSITION ID IS D_1290042443. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.7 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40235 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 42.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.16000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 54.99750 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18160 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.8 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1090 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17960 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.3 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET C 1 REMARK 465 MET D 0 REMARK 465 MET E 0 REMARK 465 PRO E 1 REMARK 465 ILE E 2 REMARK 465 VAL E 3 REMARK 465 GLN E 4 REMARK 465 ASN E 5 REMARK 465 LEU E 6 REMARK 465 GLN E 7 REMARK 465 GLY E 8 REMARK 465 GLN E 9 REMARK 465 MET E 10 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL E 11 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU D 71 O HOH D 2020 1.91 REMARK 500 O ALA B 101 O HOH B 2050 1.95 REMARK 500 O MET B 1 O HOH B 2001 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLY B 124 C ALY B 125 N 0.187 REMARK 500 ALY B 125 C HIS B 126 N 0.249 REMARK 500 GLY C 124 C ALY C 125 N 0.173 REMARK 500 ALY C 125 C HIS C 126 N 0.229 REMARK 500 GLY E 89 N GLY E 89 CA 0.111 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ALA B 101 N - CA - C ANGL. DEV. = -18.1 DEGREES REMARK 500 GLY B 124 O - C - N ANGL. DEV. = -10.4 DEGREES REMARK 500 ALY B 125 O - C - N ANGL. DEV. = -14.2 DEGREES REMARK 500 ARG C 69 NE - CZ - NH1 ANGL. DEV. = 3.9 DEGREES REMARK 500 ALY C 125 O - C - N ANGL. DEV. = -11.9 DEGREES REMARK 500 GLY E 89 N - CA - C ANGL. DEV. = -16.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP B 13 53.61 35.37 REMARK 500 PHE B 60 -75.42 -130.65 REMARK 500 PHE C 60 -79.82 -124.51 REMARK 500 ALA D 31 -138.26 61.13 REMARK 500 ALA E 31 -104.81 42.90 REMARK 500 HIS E 62 40.72 34.77 REMARK 500 HIS E 120 155.35 -22.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ALA E 88 GLY E 89 -142.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 ALY B 125 23.78 REMARK 500 ALY C 125 20.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH D2011 DISTANCE = 5.89 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1VBS RELATED DB: PDB REMARK 900 STRUCTURE OF CYCLOPHILIN COMPLEXED WITH (D) ALA CONTAINING REMARK 900 TETRAPEPTIDE REMARK 900 RELATED ID: 1OCA RELATED DB: PDB REMARK 900 HUMAN CYCLOPHILIN A, UNLIGATED, NMR, 20 STRUCTURES REMARK 900 RELATED ID: 1MF8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CALCINEURIN COMPLEXED WITHCYCLOSPORIN A REMARK 900 AND HUMAN CYCLOPHILIN REMARK 900 RELATED ID: 2CYH RELATED DB: PDB REMARK 900 CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE ALA- PRO REMARK 900 RELATED ID: 1CWB RELATED DB: PDB REMARK 900 RELATED ID: 1VBT RELATED DB: PDB REMARK 900 STRUCTURE OF CYCLOPHILIN COMPLEXED WITH SULFUR -SUBSTITUTED REMARK 900 TETRAPEPTIDE AAPF REMARK 900 RELATED ID: 1CWL RELATED DB: PDB REMARK 900 HUMAN CYCLOPHILIN A COMPLEXED WITH 4 4- HYDROXY-MELEU CYCLOSPORIN REMARK 900 RELATED ID: 1M9E RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/ HIV-1 CA N-TERMINAL REMARK 900 DOMAIN (1-146) M- TYPE H87A COMPLEX. REMARK 900 RELATED ID: 1CWC RELATED DB: PDB REMARK 900 RELATED ID: 1CWI RELATED DB: PDB REMARK 900 HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL 3 -(N-METHYL)-D-ALANINE REMARK 900 CYCLOSPORIN REMARK 900 RELATED ID: 1CWO RELATED DB: PDB REMARK 900 HUMAN CYCLOPHILIN A COMPLEXED WITH THR2, LEU5, D-HIV8, LEU10 REMARK 900 CYCLOSPORIN REMARK 900 RELATED ID: 1RMH RELATED DB: PDB REMARK 900 RECOMBINANT CYCLOPHILIN A FROM HUMAN T CELL REMARK 900 RELATED ID: 1CWJ RELATED DB: PDB REMARK 900 HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL 3 -S-METHYL-SARCOSINE REMARK 900 CYCLOSPORIN REMARK 900 RELATED ID: 2RMB RELATED DB: PDB REMARK 900 CYCLOPHILIN A COMPLEXED WITH DIMETHYL- CYCLOSPORIN A REMARK 900 RELATED ID: 1M9C RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/ HIV-1 CA N-TERMINAL REMARK 900 DOMAIN (1-146) M- TYPE COMPLEX. REMARK 900 RELATED ID: 1CWA RELATED DB: PDB REMARK 900 RELATED ID: 1CWF RELATED DB: PDB REMARK 900 HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL CYCLOSPORIN REMARK 900 RELATED ID: 1M9Y RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/ HIV-1 CA N-TERMINAL REMARK 900 DOMAIN (1-146) M- TYPE H87A,G89A COMPLEX. REMARK 900 RELATED ID: 3CYH RELATED DB: PDB REMARK 900 CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE SER- PRO REMARK 900 RELATED ID: 4CYH RELATED DB: PDB REMARK 900 CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE HIS- PRO REMARK 900 RELATED ID: 1M9F RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/ HIV-1 CA N-TERMINAL REMARK 900 DOMAIN (1-146) M- TYPE H87A,A88M COMPLEX. REMARK 900 RELATED ID: 1CWH RELATED DB: PDB REMARK 900 HUMAN CYCLOPHILIN A COMPLEXED WITH 3-D-SER CYCLOSPORIN REMARK 900 RELATED ID: 1BCK RELATED DB: PDB REMARK 900 HUMAN CYCLOPHILIN A COMPLEXED WITH 2-THR CYCLOSPORIN REMARK 900 RELATED ID: 1W8V RELATED DB: PDB REMARK 900 ENZYMATIC AND STRUCTURAL CHARACTERIZATION OF NON PEPTIDE LIGAND REMARK 900 CYCLOPHILIN COMPLEXES REMARK 900 RELATED ID: 1AWR RELATED DB: PDB REMARK 900 CYPA COMPLEXED WITH HAGPIA REMARK 900 RELATED ID: 1NMK RELATED DB: PDB REMARK 900 THE SANGLIFEHRIN-CYCLOPHILIN INTERACTION: DEGRADATION WORK, REMARK 900 SYNTHETIC MACROCYCLIC ANALOGUES , X-RAY CRYSTAL STRUCTUREAND REMARK 900 BINDING DATA REMARK 900 RELATED ID: 1MIK RELATED DB: PDB REMARK 900 RELATED ID: 1AWV RELATED DB: PDB REMARK 900 CYPA COMPLEXED WITH HVGPIA REMARK 900 RELATED ID: 1M9D RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/ HIV-1 CA N-TERMINAL REMARK 900 DOMAIN (1-146) O- TYPE CHIMERA COMPLEX. REMARK 900 RELATED ID: 2CPL RELATED DB: PDB REMARK 900 CYCLOPHILIN A REMARK 900 RELATED ID: 2X2A RELATED DB: PDB REMARK 900 FREE ACETYL-CYPA TRIGONAL FORM REMARK 900 RELATED ID: 1FGL RELATED DB: PDB REMARK 900 CYCLOPHILIN A COMPLEXED WITH A FRAGMENT OF HIV-1 GAGPROTEIN REMARK 900 RELATED ID: 1AWT RELATED DB: PDB REMARK 900 SECYPA COMPLEXED WITH HAGPIA REMARK 900 RELATED ID: 1M9X RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF CYCLOPHILIN A/ HIV-1 CA N-TERMINAL REMARK 900 DOMAIN (1-146) M- TYPE H87A,A88M,G89A COMPLEX. REMARK 900 RELATED ID: 1M63 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CALCINEURIN-CYCLOPHILIN- CYCLOSPORINSHOWS REMARK 900 COMMON BUT DISTINCT RECOGNITION OF IMMUNOPHILIN-DRUGCOMPLEXES REMARK 900 RELATED ID: 1CWK RELATED DB: PDB REMARK 900 HUMAN CYCLOPHILIN A COMPLEXED WITH 1-(6,7 -DIHYDRO)MEBMT 2-VAL 3-D- REMARK 900 (2-S-METHYL) SARCOSINE CYCLOSPORIN REMARK 900 RELATED ID: 5CYH RELATED DB: PDB REMARK 900 CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE GLY- PRO REMARK 900 RELATED ID: 1AK4 RELATED DB: PDB REMARK 900 HUMAN CYCLOPHILIN A BOUND TO THE AMINO- TERMINAL DOMAIN OF HIV-1 REMARK 900 CAPSID REMARK 900 RELATED ID: 1W8L RELATED DB: PDB REMARK 900 ENZYMATIC AND STRUCTURAL CHARACTERIZATION OF NON PEPTIDE LIGAND REMARK 900 CYCLOPHILIN COMPLEXES REMARK 900 RELATED ID: 1AWS RELATED DB: PDB REMARK 900 SECYPA COMPLEXED WITH HAGPIA (PSEUDO-SYMMETRIC MONOMER) REMARK 900 RELATED ID: 3CYS RELATED DB: PDB REMARK 900 CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN A ( NMR, 22 STRUCTURES) REMARK 900 RELATED ID: 2ALF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYPA MUTANT K131A REMARK 900 RELATED ID: 2X25 RELATED DB: PDB REMARK 900 FREE ACETYL-CYPA ORTHOROMBIC FORM REMARK 900 RELATED ID: 1AWU RELATED DB: PDB REMARK 900 CYPA COMPLEXED WITH HVGPIA (PSEUDO-SYMMETRIC MONOMER) REMARK 900 RELATED ID: 1W8M RELATED DB: PDB REMARK 900 ENZYMATIC AND STRUCTURAL CHARACTERISATION OF NON PEPTIDE LIGAND REMARK 900 CYCLOPHILIN COMPLEXES REMARK 900 RELATED ID: 2C55 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 P6 REMARK 900 PROTEIN REMARK 900 RELATED ID: 1CWM RELATED DB: PDB REMARK 900 HUMAN CYCLOPHILIN A COMPLEXED WITH 4 MEILE CYCLOSPORIN REMARK 900 RELATED ID: 2RMA RELATED DB: PDB REMARK 900 CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1AWQ RELATED DB: PDB REMARK 900 CYPA COMPLEXED WITH HAGPIA (PSEUDO-SYMMETRIC MONOMER) REMARK 900 RELATED ID: 2X2C RELATED DB: PDB REMARK 900 ACETYL-CYPA:CYCLOSPORINE COMPLEX DBREF 2X2D B 1 165 UNP P62937 PPIA_HUMAN 1 165 DBREF 2X2D C 1 165 UNP P62937 PPIA_HUMAN 1 165 DBREF 2X2D D 0 0 PDB 2X2D 2X2D 0 0 DBREF 2X2D D 1 146 UNP P12493 GAG_HV1N5 133 278 DBREF 2X2D E 0 0 PDB 2X2D 2X2D 0 0 DBREF 2X2D E 1 146 UNP P12493 GAG_HV1N5 133 278 SEQRES 1 B 165 MET VAL ASN PRO THR VAL PHE PHE ASP ILE ALA VAL ASP SEQRES 2 B 165 GLY GLU PRO LEU GLY ARG VAL SER PHE GLU LEU PHE ALA SEQRES 3 B 165 ASP LYS VAL PRO LYS THR ALA GLU ASN PHE ARG ALA LEU SEQRES 4 B 165 SER THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER CYS SEQRES 5 B 165 PHE HIS ARG ILE ILE PRO GLY PHE MET CYS GLN GLY GLY SEQRES 6 B 165 ASP PHE THR ARG HIS ASN GLY THR GLY GLY LYS SER ILE SEQRES 7 B 165 TYR GLY GLU LYS PHE GLU ASP GLU ASN PHE ILE LEU LYS SEQRES 8 B 165 HIS THR GLY PRO GLY ILE LEU SER MET ALA ASN ALA GLY SEQRES 9 B 165 PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR ALA SEQRES 10 B 165 LYS THR GLU TRP LEU ASP GLY ALY HIS VAL VAL PHE GLY SEQRES 11 B 165 LYS VAL LYS GLU GLY MET ASN ILE VAL GLU ALA MET GLU SEQRES 12 B 165 ARG PHE GLY SER ARG ASN GLY LYS THR SER LYS LYS ILE SEQRES 13 B 165 THR ILE ALA ASP CYS GLY GLN LEU GLU SEQRES 1 C 165 MET VAL ASN PRO THR VAL PHE PHE ASP ILE ALA VAL ASP SEQRES 2 C 165 GLY GLU PRO LEU GLY ARG VAL SER PHE GLU LEU PHE ALA SEQRES 3 C 165 ASP LYS VAL PRO LYS THR ALA GLU ASN PHE ARG ALA LEU SEQRES 4 C 165 SER THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER CYS SEQRES 5 C 165 PHE HIS ARG ILE ILE PRO GLY PHE MET CYS GLN GLY GLY SEQRES 6 C 165 ASP PHE THR ARG HIS ASN GLY THR GLY GLY LYS SER ILE SEQRES 7 C 165 TYR GLY GLU LYS PHE GLU ASP GLU ASN PHE ILE LEU LYS SEQRES 8 C 165 HIS THR GLY PRO GLY ILE LEU SER MET ALA ASN ALA GLY SEQRES 9 C 165 PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR ALA SEQRES 10 C 165 LYS THR GLU TRP LEU ASP GLY ALY HIS VAL VAL PHE GLY SEQRES 11 C 165 LYS VAL LYS GLU GLY MET ASN ILE VAL GLU ALA MET GLU SEQRES 12 C 165 ARG PHE GLY SER ARG ASN GLY LYS THR SER LYS LYS ILE SEQRES 13 C 165 THR ILE ALA ASP CYS GLY GLN LEU GLU SEQRES 1 D 147 MET PRO ILE VAL GLN ASN LEU GLN GLY GLN MET VAL HIS SEQRES 2 D 147 GLN ALA ILE SER PRO ARG THR LEU ASN ALA TRP VAL LYS SEQRES 3 D 147 VAL VAL GLU GLU LYS ALA PHE SER PRO GLU VAL ILE PRO SEQRES 4 D 147 MET PHE SER ALA LEU SER GLU GLY ALA THR PRO GLN ASP SEQRES 5 D 147 LEU ASN THR MET LEU ASN THR VAL GLY GLY HIS GLN ALA SEQRES 6 D 147 ALA MET GLN MET LEU LYS GLU THR ILE ASN GLU GLU ALA SEQRES 7 D 147 ALA GLU TRP ASP ARG LEU HIS PRO VAL HIS ALA GLY PRO SEQRES 8 D 147 ILE ALA PRO GLY GLN MET ARG GLU PRO ARG GLY SER ASP SEQRES 9 D 147 ILE ALA GLY THR THR SER THR LEU GLN GLU GLN ILE GLY SEQRES 10 D 147 TRP MET THR HIS ASN PRO PRO ILE PRO VAL GLY GLU ILE SEQRES 11 D 147 TYR LYS ARG TRP ILE ILE LEU GLY LEU ASN LYS ILE VAL SEQRES 12 D 147 ARG MET TYR SER SEQRES 1 E 147 MET PRO ILE VAL GLN ASN LEU GLN GLY GLN MET VAL HIS SEQRES 2 E 147 GLN ALA ILE SER PRO ARG THR LEU ASN ALA TRP VAL LYS SEQRES 3 E 147 VAL VAL GLU GLU LYS ALA PHE SER PRO GLU VAL ILE PRO SEQRES 4 E 147 MET PHE SER ALA LEU SER GLU GLY ALA THR PRO GLN ASP SEQRES 5 E 147 LEU ASN THR MET LEU ASN THR VAL GLY GLY HIS GLN ALA SEQRES 6 E 147 ALA MET GLN MET LEU LYS GLU THR ILE ASN GLU GLU ALA SEQRES 7 E 147 ALA GLU TRP ASP ARG LEU HIS PRO VAL HIS ALA GLY PRO SEQRES 8 E 147 ILE ALA PRO GLY GLN MET ARG GLU PRO ARG GLY SER ASP SEQRES 9 E 147 ILE ALA GLY THR THR SER THR LEU GLN GLU GLN ILE GLY SEQRES 10 E 147 TRP MET THR HIS ASN PRO PRO ILE PRO VAL GLY GLU ILE SEQRES 11 E 147 TYR LYS ARG TRP ILE ILE LEU GLY LEU ASN LYS ILE VAL SEQRES 12 E 147 ARG MET TYR SER MODRES 2X2D ALY B 125 LYS N(6)-ACETYLLYSINE MODRES 2X2D ALY C 125 LYS N(6)-ACETYLLYSINE HET ALY B 125 12 HET ALY C 125 12 HETNAM ALY N(6)-ACETYLLYSINE FORMUL 1 ALY 2(C8 H16 N2 O3) FORMUL 5 HOH *208(H2 O) HELIX 1 1 VAL B 29 GLY B 42 1 14 HELIX 2 2 THR B 119 ASP B 123 5 5 HELIX 3 3 GLY B 135 GLU B 143 1 9 HELIX 4 4 ARG B 144 GLY B 146 5 3 HELIX 5 5 VAL C 29 GLY C 42 1 14 HELIX 6 6 THR C 119 ASP C 123 5 5 HELIX 7 7 GLY C 135 ARG C 144 1 10 HELIX 8 8 SER D 16 ALA D 31 1 16 HELIX 9 9 GLU D 35 SER D 44 1 10 HELIX 10 10 THR D 48 THR D 58 1 11 HELIX 11 11 HIS D 62 HIS D 84 1 23 HELIX 12 12 ARG D 100 ALA D 105 1 6 HELIX 13 13 THR D 110 HIS D 120 1 11 HELIX 14 14 PRO D 125 VAL D 142 1 18 HELIX 15 15 ARG D 143 SER D 146 5 4 HELIX 16 16 SER E 16 LYS E 30 1 15 HELIX 17 17 GLU E 35 SER E 44 1 10 HELIX 18 18 THR E 48 VAL E 59 1 12 HELIX 19 19 HIS E 62 HIS E 84 1 23 HELIX 20 20 ARG E 100 ALA E 105 1 6 HELIX 21 21 THR E 110 HIS E 120 1 11 HELIX 22 22 PRO E 125 SER E 146 1 22 SHEET 1 BA 8 PHE B 53 ILE B 57 0 SHEET 2 BA 8 MET B 61 GLY B 64 -1 O MET B 61 N ILE B 57 SHEET 3 BA 8 PHE B 112 CYS B 115 -1 O PHE B 112 N GLY B 64 SHEET 4 BA 8 ILE B 97 MET B 100 -1 O ILE B 97 N CYS B 115 SHEET 5 BA 8 VAL B 128 GLU B 134 -1 N PHE B 129 O LEU B 98 SHEET 6 BA 8 GLU B 15 LEU B 24 -1 O SER B 21 N LYS B 133 SHEET 7 BA 8 THR B 5 VAL B 12 -1 O VAL B 6 N PHE B 22 SHEET 8 BA 8 ILE B 156 LEU B 164 -1 O THR B 157 N ALA B 11 SHEET 1 CA 8 PHE C 53 ILE C 57 0 SHEET 2 CA 8 MET C 61 GLY C 64 -1 O MET C 61 N ILE C 57 SHEET 3 CA 8 PHE C 112 CYS C 115 -1 O PHE C 112 N GLY C 64 SHEET 4 CA 8 ILE C 97 MET C 100 -1 O ILE C 97 N CYS C 115 SHEET 5 CA 8 VAL C 128 GLU C 134 -1 N PHE C 129 O LEU C 98 SHEET 6 CA 8 GLU C 15 LEU C 24 -1 O SER C 21 N LYS C 133 SHEET 7 CA 8 THR C 5 VAL C 12 -1 O VAL C 6 N PHE C 22 SHEET 8 CA 8 ILE C 156 GLN C 163 -1 O THR C 157 N ALA C 11 SHEET 1 DA 2 ILE D 2 GLN D 4 0 SHEET 2 DA 2 MET D 10 HIS D 12 -1 O VAL D 11 N VAL D 3 LINK C GLY B 124 N ALY B 125 1555 1555 1.52 LINK C ALY B 125 N HIS B 126 1555 1555 1.59 LINK C GLY C 124 N ALY C 125 1555 1555 1.51 LINK C ALY C 125 N HIS C 126 1555 1555 1.57 CISPEP 1 GLY D 89 PRO D 90 0 14.43 CISPEP 2 ASN D 121 PRO D 122 0 14.11 CISPEP 3 GLY E 89 PRO E 90 0 10.73 CISPEP 4 ASN E 121 PRO E 122 0 -20.78 CRYST1 38.542 109.995 67.567 90.00 101.11 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025946 0.000000 0.005095 0.00000 SCALE2 0.000000 0.009091 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015083 0.00000